COMMONWEALTH OF AUSTRALIA

Instrument number PB 59 of 2009

National Health (Pharmaceutical Benefits – Early Supply) Amendment, July 2009 - Specification Under Subsection 84AAA(2)

 

Amendment determination under subsection 84AAA(2) of the National Health Act 1953

 

I, Linda Jackson, Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.

 

Dated 4 June 2009

 

 

LINDA JACKSON

Assistant Secretary

Pharmaceutical Evaluation Branch

Department of Health and Ageing

 

 

 

Amendment determination — Pharmaceutical Benefits-Early Supply

 

 

1 Name of Instrument

 

(1)           This Instrument is the National Health Act (Pharmaceutical Benefits – Early Supply) Amendment, July 2009 - specification under subsection 84AAA(2).

 

(2)           This Instrument may also be cited as “No. PB 59 of 2009”.


2 Commencement

 

This Instrument commences on 1 July 2009.

 

 

3 Amendment of PB 30 of 2009

 

Schedule 1 amends the National Health (Pharmaceutical Benefits – Early Supply) Instrument 2009, PB 30 of 2009.

 

Schedule 1 Amendments

[1]                                   Schedule 1, item dealing with Oestradiol and oestradiol with norethisterone

omit from the columns in the order indicated:

 

 

Pack containing 12 tablets oestradiol 2 mg, 10 tablets oestradiol 2 mg with norethisterone acetate 1 mg and 6 tablets oestradiol 1 mg

Oral

1

5

 

Tablets containing 1 mg oestradiol (as hemihydrate) with 500 micrograms norethisterone acetate, 28

Oral

1

5

 

Tablets containing 2 mg oestradiol (as hemihydrate) with 1 mg norethisterone acetate, 28

Oral

1

5

 

 

[2]                                   Schedule 1, after item dealing with Risedronate sodium

insert in the columns in the order indicated:

 

Risedronic acid

Tablet containing risedronate sodium 150 mg

Oral

1

5